Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
E2022
- Development stage
- Phase 1
- Administration
- Transdermal
01
Overview
E2022 is an investigational drug studied in a patch (tape) formulation, with clinical research focused on evaluating its safety and pharmacokinetics. The available information indicates that it has been tested in a Phase 1 comparative study to assess different patch formulations, but specific details about its mechanism of action, therapeutic target, or primary indication are not provided in the accessible sources. No further data regarding its molecular class or disease focus is available from current public records[1].
Beyond the preview
Go deeper on E2022.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on E2022.